Dai G - Search Results

1

Erratum for the research article "The suppressive efficacy of THZ1 depends on KRAS mutation subtype and is associated with super-enhancer activity and the PI3K/AKT/mTOR signalling in pancreatic ductal adenocarcinoma: A hypothesis-generating study" by Huang et al.

Huang L, Yang H, Chen K, Yuan J, Li J, Dai G, Gu M, Shi Y. Huang L, et al. Among authors: dai g. Clin Transl Med. 2025 Jan;15(1):e70158. doi: 10.1002/ctm2.70158. Clin Transl Med. 2025. PMID: 39731275 Free PMC article. No abstract available.

2

[Expressions of Raf-1 kinase, phosphorylated mitogen extracellular kinase 1, and phosphorylated extracellular signal-regulated protein kinase 1/2 in hepatocellular carcinoma and their relationship with prognosis].

Chen L, Shi Y, Jiang CY, Sun Q, Dai GH. Chen L, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):424-8. doi: 10.3881/j.issn.1000-503X.2010.04.014. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20868603 Chinese.

3

Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.

Chen L, Shi Y, Jiang CY, Wei LX, Lv YL, Wang YL, Dai GH. Chen L, et al. Int J Biol Markers. 2011 Apr-Jun;26(2):108-16. doi: 10.5301/JBM.2011.8322. Int J Biol Markers. 2011. PMID: 21574155 Free article.

4

[Expression of leptin and leptin receptor in hepatocellular carcinoma and the clinicopathological significance].

Chen L, Shi Y, Jiang CY, Sun Q, Wang LX, Dai GH. Chen L, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2011 May;31(5):830-3. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21602135 Chinese.

5

Trastuzumab combined with docetaxel-based regimens in previously treated metastatic gastric cancer patients with HER2 over-expression.

Dai GH, Shi Y, Chen L, Lv YL, Zhong M. Dai GH, et al. Hepatogastroenterology. 2012 Nov-Dec;59(120):2439-44. doi: 10.5754/hge12166. Hepatogastroenterology. 2012. PMID: 22534547 Clinical Trial.

6

Sorafenib combined with TACE in advanced primary hepatocellular carcinoma.

Cui HZ, Dai GH, Shi Y, Chen L. Cui HZ, et al. Hepatogastroenterology. 2013 Mar-Apr;60(122):305-10. doi: 10.5754/hge12552. Hepatogastroenterology. 2013. PMID: 23574656

7

Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma.

Shi Y, Qin R, Wang ZK, Dai GH. Shi Y, et al. Onco Targets Ther. 2013 May 27;6:585-91. doi: 10.2147/OTT.S44406. Print 2013. Onco Targets Ther. 2013. PMID: 23737672 Free PMC article.

8

[Prognostic Factors of Stage 3 Colorectal Cancer in 433 Patients].

Sun DC, Mao H, Wang ZK, Shi Y, Dai GH. Sun DC, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015 Oct;37(5):549-56. doi: 10.3881/j.issn.1000-503X.2015.05.010. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2015. PMID: 26564506 Chinese.

9

Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis.

Sun DC, Shi Y, Wang LX, Lv Y, Han QL, Wang ZK, Dai GH. Sun DC, et al. Oncotarget. 2017 Mar 16;8(39):66550-66558. doi: 10.18632/oncotarget.16289. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029535 Free PMC article.

10

KRAS mutation and primary tumor location do not affect efficacy of bevacizumab-containing chemotherapy in stagae IV colorectal cancer patients.

Sun DC, Shi Y, Wang YR, Lv Y, Yan H, Mao H, Wang ZK, Wu ZY, Shi WW, Dai GH. Sun DC, et al. Sci Rep. 2017 Oct 30;7(1):14368. doi: 10.1038/s41598-017-14669-2. Sci Rep. 2017. PMID: 29085005 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,054 results

Search Page

Filters